LogicBio Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference

Rhea-AI Summary

LogicBio Therapeutics (Nasdaq: LOGC) announced that CEO Fred Chereau will participate in a fireside chat at the 2021 Cantor Virtual Global Healthcare Conference on September 29, 2021, at 8:00 a.m. ET. The event will be accessible via a live webcast on the company's investors section of their website, with a replay available for 30 days. LogicBio Therapeutics focuses on gene editing and delivery to address rare diseases using innovative platforms like GeneRide™ and sAAVy™.

LEXINGTON, Mass., Sept. 24, 2021 /PRNewswire/ -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a clinical-stage genetic medicine company pioneering gene editing and gene delivery platforms to address rare and serious diseases from infancy through adulthood, today announced that president and chief executive officer, Fred Chereau, will participate in a fireside chat at the 2021 Cantor Virtual Global Healthcare Conference on Wednesday, September 29, 2021 at 8:00 a.m. ET.

A live webcast of the fireside chat will be made available on the Investors section of the Company's website at www.logicbio.com/investors. The webcast replay will be available for approximately 30 days.

About LogicBio Therapeutics 
LogicBio Therapeutics is a clinical-stage genetic medicine company pioneering gene editing and gene delivery platforms to address rare and serious diseases from infancy through adulthood. The Company's gene editing platform, GeneRide™, is a new approach to precise gene insertion harnessing a cell's natural DNA repair process potentially leading to durable therapeutic protein expression levels. The Company's gene delivery platform, sAAVy™, is an adeno-associated virus (AAV) capsid engineering platform designed to optimize gene delivery for treatments in a broad range of indications and tissues. The Company is based in Lexington, MA. For more information, visit www.logicbio.com, which does not form a part of this release.

Investor Contacts: 
Laurence Watts
Gilmartin Group
(619) 916-7620
laurence@gilmartinir.com 

Stephen Jasper
Gilmartin Group
(858) 525-2047
stephen@gilmartinir.com 

Media Contacts:
Adam Daley
Berry & Company Public Relations
W: 212-253-8881
C: 614-580-2048
adaley@berrypr.com 

Jenna Urban
Berry & Company Public Relations
W: 212-253-8881
C: 203-218-9180
jurban@berrypr.com 

View original content:https://www.prnewswire.com/news-releases/logicbio-therapeutics-to-participate-in-the-2021-cantor-virtual-global-healthcare-conference-301384769.html

SOURCE LogicBio Therapeutics, Inc.

FAQ

When is LogicBio Therapeutics participating in the 2021 Cantor Virtual Global Healthcare Conference?

LogicBio Therapeutics will participate in the 2021 Cantor Virtual Global Healthcare Conference on September 29, 2021, at 8:00 a.m. ET.

Who is the CEO of LogicBio Therapeutics?

The CEO of LogicBio Therapeutics is Fred Chereau.

How can I watch the LogicBio Therapeutics fireside chat?

You can watch the LogicBio Therapeutics fireside chat by accessing the live webcast on the investors section of their website.

What platforms does LogicBio Therapeutics use for gene editing?

LogicBio Therapeutics uses the GeneRide™ platform for gene editing and sAAVy™ for gene delivery.

How long will the LogicBio Therapeutics webcast replay be available?

The webcast replay for the LogicBio Therapeutics event will be available for approximately 30 days.